Botanical species · safety record

Strychnos potatorum

The EFSA Compendium of Botanicals holds 6 constituent measurements and 1 adverse-effect record for Strychnos potatorum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Strychnos potatorum L.f.

6Constituent measurements

1Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Harmane alkaloids	Bark	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Anthraquinones	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Indole alkaloids	Unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Testes	Seed	Solvent extraction	Rat (as animal)	Subchronic	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gupta, R.S., Kanwar, M., Kachhawa, J.B.S. Effect of methanol seed extract of Strychnos potatorum on accessory sex organs of male albino rats. Pharmacologyonline, 2007, vol. 1, p. 79-83.
Massiot, Georges., Thepenier, Philippe., Jacquier, Marie Jose., Le Men-Olivier, Louisette., Delaude, Clement. Normavacurine and minfiensine, two new alkaloids with C19H22N2O formula from Strychnos species. Heterocycles, 1989, p. 1435-1438.
Sivagnanam, Selva Kumar., Rao, Ram Krishna., Mudiganti., Dar, Umar Mushtaq., Jeelani, Peerzada Gh. Preliminary phytochemical analysis of Artemesia amygdalina, Nerium odorum and Strychnos potatorum. Journal of Pharmacy Research, 2012, p. 3734-3739.
MASSIOT, G., THEPENIER, P., JACOUIER, MJ., LEMENOLIVIER, L., DELAUDE, C. ALKALOIDS FROM ROOTS OF STRYCHNOS-POTATORUM. Phytochemistry, 1992, vol. 31, no. 8, p. 2873-2876. DOI
Singh, Harkisham., Kapoor, K. V. Investigation of Strychnos spp. IV. Pharmacological studies of alkaloids of Strychnos potatorum. Planta medica, 1976, p. 226-233.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature